Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LK8U
|
|||
| Former ID |
DNC002337
|
|||
| Drug Name |
CG-1521
|
|||
| Synonyms |
CG-1521; UNII-028K52V859; 028K52V859; 2,4,6-Heptatrienamide, N-hydroxy-7-phenyl-, (2E,4E,6E)-; 674767-29-4; CHEMBL159249; SCHEMBL10323570; DBBYYRWVNDQECM-CDWOPPGASA-N; N-hydroxy-7-phenylhepta-2,4,6-trienamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H13NO2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C=CC=CC=CC(=O)NO
|
|||
| InChI |
1S/C13H13NO2/c15-13(14-16)11-7-2-1-4-8-12-9-5-3-6-10-12/h1-11,16H,(H,14,15)/b2-1+,8-4+,11-7+
|
|||
| InChIKey |
DBBYYRWVNDQECM-CDWOPPGASA-N
|
|||
| CAS Number |
CAS 674767-29-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| ChEBI ID |
CHEBI:156510
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase (HDAC) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.